Skip to main content
Livermore
Livermore
ZHEN

ING Groep NV

SEC CIK
0001039765
Latest filing
Aug 13, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by ING Groep NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
337,408
Value
$30.5M
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of EW by ING Groep NV, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026337,408$30.5M0.1%−114,239−25.3%ReducedHolders
Q1 2026451,647$36.2M0.2%+120,652+36.5%AddedHolders
Q4 2025330,995$28.2M0.2%+277,697+521.0%AddedHolders
Q3 202553,298$4.14M<0.1%−27,387−33.9%ReducedHolders
Q2 202580,685$6.31M<0.1%−131,726−62.0%ReducedHolders
Q1 2025212,411$15.4M0.1%+137,081+182.0%AddedHolders
Q4 202475,330$5.58M<0.1%−5,235−6.5%ReducedHolders
Q3 202480,565$5.32M<0.1%−522−0.6%ReducedHolders
Q2 202481,087$7.49M<0.1%−2,022−2.4%ReducedHolders
Q1 202483,109$7.94M0.1%−30,423−26.8%ReducedHolders
Q4 2023113,532$8.66M0.1%−97,787−46.3%ReducedHolders
Q3 2023211,319$14.6M0.1%+211,319NewHolders
Q2 20230$00.0%−105,060−100.0%Sold outHolders
Q1 2023105,060$8.69M0.1%−66,759−38.9%ReducedHolders
Q4 2022171,819$12.8M0.1%+74,655+76.8%AddedHolders
Q3 202297,164$8.03M0.1%−19,836−17.0%ReducedHolders
Q2 2022117,000$11.1M0.1%+17,946+18.1%AddedHolders
Q1 202299,054$11.7M0.1%−56,432−36.3%ReducedHolders
Q4 2021155,486$20.1M0.2%+29,155+23.1%AddedHolders
Q3 2021126,331$14.3M0.2%+75,276+147.4%AddedHolders
Q2 202151,055$5.29M0.1%+9,706+23.5%AddedHolders
Q1 202141,349$3.46M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.